(Q40586132)

21 September 2017

title

Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports (English)

1 reference

21 September 2017

0 references

Strupp C

1

1 reference

21 September 2017

Aivado M

2

1 reference

21 September 2017

Germing U

3

1 reference

21 September 2017

Gattermann N

4

1 reference

21 September 2017

Haas R

5

1 reference

21 September 2017

publication date

1 January 2002

1 reference

21 September 2017

1 reference

21 September 2017

volume

43

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

133-137

1 reference

Angioimmunoblastic lymphadenopathy: Clinical spectrum of disease

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

High-dose chemotherapy and APSCT as a potential cure for relapsing hemolysing AILD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

Selective down-regulation of T cell- and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

Thalidomide and the immune system. 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210190

21 January 2018

Identifiers

DOI

10.1080/10428190210190

1 reference

21 September 2017

1 reference